These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15569914)

  • 1. Catatonia in psychiatric classification.
    Van Den Eede F; Sabbe B
    Am J Psychiatry; 2004 Dec; 161(12):2327-8; author reply 2328. PubMed ID: 15569914
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW
    J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Catatonia, malignant neuroleptic syndrome and myositis ossificans].
    Topka H; Buchkremer G
    Nervenarzt; 1996 May; 67(5):413-7. PubMed ID: 9005354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catatonia, neuroleptics and brain damage--a case report.
    Chandran M; El-Shazly M
    J Psychopharmacol; 2009 Mar; 23(2):223-6. PubMed ID: 18562406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine and catatonia.
    Gingrich JA; Rudnick-Levin F; Almeida C; Innes L; Schneier H
    Am J Psychiatry; 1998 Nov; 155(11):1629. PubMed ID: 9812136
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome and catatonia: one entity or two?
    Fink M
    Biol Psychiatry; 1996 Jan; 39(1):1-4. PubMed ID: 8719118
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal hyperthermia syndrome.
    Am J Psychiatry; 1991 Oct; 148(10):1411-2. PubMed ID: 1680297
    [No Abstract]   [Full Text] [Related]  

  • 9. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD; Hake L; Benjamin AB; Adityanjee A
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical antipsychotics and neuroleptic malignant syndrome.
    Velamoor VR
    Can J Psychiatry; 2001 Nov; 46(9):865-6. PubMed ID: 11761644
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
    Heils A; Lesch KP
    Fortschr Neurol Psychiatr; 1997 Jan; 65(1):8-15. PubMed ID: 9132369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].
    Asztalos Z; Egervári L; Andrássy G; Faludi G; Frecska E
    Neuropsychopharmacol Hung; 2014 Mar; 16(1):19-28. PubMed ID: 24687015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lethal catatonia and its differential diagnosis with the neuroleptic malignant syndrome].
    Andreu Giménez L; Robert Gates J; Jover Díaz F; Pagán Acosta G; Merino Sánchez J
    Rev Neurol; 2002 Feb 16-28; 34(4):399-400. PubMed ID: 12022063
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia.
    Fink M; Taylor MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1182-3; author reply 1184-5. PubMed ID: 16675086
    [No Abstract]   [Full Text] [Related]  

  • 15. [Catatonia and neuroleptic malignant syndrome in a mentally retarded patient].
    Heikkilä J; Raitasuo S; Lauerma H; Mölsä P
    Duodecim; 1992; 108(12):1120-4. PubMed ID: 1366062
    [No Abstract]   [Full Text] [Related]  

  • 16. [Catatonia].
    Pot AL; Lejoyeux M
    Encephale; 2015 Jun; 41(3):274-9. PubMed ID: 25858694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catatonia: a syndrome appears, disappears, and is rediscovered.
    Fink M
    Can J Psychiatry; 2009 Jul; 54(7):437-45. PubMed ID: 19660165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caution is still needed when prescribing atypical antipsychotics.
    Carey S
    Br J Hosp Med (Lond); 2008 May; 69(5):299. PubMed ID: 18557562
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical risk factors for neuroleptic malignant syndrome.
    Berardi D; Dell'Atti M; Amore M; De Ronchi D; Ferrari G
    Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for neuroleptic malignant syndrome.
    Francis A; Chandragiri S; Petrides G
    Am J Psychiatry; 1998 Nov; 155(11):1639-40. PubMed ID: 9812151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.